Physician profile
Saad Bhatti
NPI 1891960316
$787.62
in general payments reported to CMS, 2019-2025
13 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $57.60 · 2021: $33.94 · 2023: $86.01 · 2024: $97.51 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $150.72 | 2021-2025 | Cleviprex, Kengreal |
| Abbvie INC. | $142.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $131.88 | 2019-2023 | Xarelto |
| Shionogi INC | $120.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.00 | 2025 | |
| Ceribell, INC. | $44.43 | 2025 | Pocket Eeg Device |
| Ardelyx, INC. | $27.76 | 2024 | Ibsrela |
| Travere Therapeutics, INC. | $23.93 | 2025 | Filspari |
| Amgen INC. | $22.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.04 | 2019 | |
| Medtronic Vascular, INC. | $18.27 | 2020 | |
| Covidien LP | $18.00 | 2019 | |
| Aurinia Pharma U.S., INC. | $17.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saad Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.